Purdue Pharma, which is owned by the Sackler family, manufactures and markets OxyContin -- one of the prescription ...
A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement resolving claims that it fueled the U.
NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...
A federal bankruptcy court judge said Friday he'll approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of ...
The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than 54,000 ...
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, based on ...
A federal judge rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic Thursday because of a provision that would protect members of the ...
Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities and individuals who say they were harmed by the company’s addictive ...
The company that makes the prescription painkiller OxyContin would be transformed into a new entity that would funnel profits into combatting the U.S. opioid crisis under a $10 billion plan submitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results